Beta Bionics (BBNX) Stock: Buy, Sell, or Hold?
BBNX - Beta Bionics, Inc. Common Stock
$22.18
2.95 (15.34%)
▲
5d:
+27.32%
30d:
+26.31%
90d:
+59.0%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When BBNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BBNX is 10.5% above its trading range ($20.07). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BBNX is 10.5% above its trading range ($20.07). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BBNX is currently trading at $22.18, which is considered extended relative to its 30-day fair value range of $17.38 to $20.07.
Technical Outlook: Technically, BBNX is in a strong uptrend. The price is approaching resistance at $22.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.3% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBNX is in a strong uptrend. The price is approaching resistance at $22.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 15.3% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.38 -
$20.07
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+10.5% above its trading range)
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.3%)
- NEUTRAL: Near Wall St target ($22.40)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$17.38 -
$20.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.51
Resistance Level
$22.22
Current Trend
Strong Uptrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.54
Wall Street Target
$22.40
(+1.0%)
Revenue Growth (YoY)
37.8%
Profit Margin
-61.3%
Share & Embed Analysis
Last updated: September 17, 2026 12:46 AM ET
Data refreshes hourly during market hours. Next update: 1:46 AM
Data refreshes hourly during market hours. Next update: 1:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$376 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 44 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 59 HOLD |
